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Background and objectives: Noninvasive home mechanical ventilation (HMV) has been shown
to be beneficial for certain forms of respiratory failure, improving symptoms and quality of
life. Adaptation and follow-up are usually conducted within the hospital framework. Our
objective was to verify whether the same results could be obtained in the patient’s home
by the Home Hospitalization Unit.
Methods: This was a prospective study of patients with stable restrictive ventilatory disorders,
who met the criteria to receive HMV. They underwent hospital adaptation (group 1) or ambu-
latory adaptation (group 2) based on geographical area. The following tests were performed
throughout the follow-up: Borg scale, respiratory function, arterial blood gases, nocturnal
pulse oximetry, a health survey questionnaire (SF-36), and initially, the Barthel index. Adapta-
tion and follow-up were performed identically in both groups in accordance with the adapta-
tion and follow-up protocol of our hospital. Independent and intergroup comparisons were
made for both groups.
Results: Forty-two patients (21 at hospital and 21 at home) were included. No initial differ-
ences were found between the two groups. Improvements were noted on the Borg scale and
for nocturnal pulse oximetry within the groups, with no differences between them. No
improvement in pulmonary function was observed in either group. Arterial blood gases
improved in both groups, but the ambulatory group recorded significantly higher values
(PO2, PZ 0.033; PCO2, PZ 0.020). Most domains of the SF-36 questionnaire improved in both
groups, although some intergroup differences were noted.386 2707.
om (R. Dome´nech-Clar).
8 Published by Elsevier Ltd.
1522 R. Dome´nech-Clar et al.Conclusions: HMV improved arterial blood gases and quality of life in patients with restrictive
ventilatory disorders. Arterial blood gases were better in the ambulatory group and the quality
of life was similar in both groups.
ª 2008 Published by Elsevier Ltd.Introduction
Noninvasive home mechanical ventilation (HMV) has
become a well-established therapeutic option for the
treatment of respiratory failure secondary to restrictive
thoracic diseases and in certain patients with acute
chronic obstructive pulmonary disease (COPD), modifying
the recovery and quality of life of many of these
patients.1,2
The clinical indications for HMV have increased in
recent years, and are well defined for the treatment of
restrictive ventilatory disorders. HMV is well known to
improve sleep structure and arterial blood gases and to
reduce hospital admission rates resulting from acute
exacerbation, thereby improving the quality of life of these
patients.3,4
Eurovent, a multicenter European survey in which
27,118 patients were included, with a mean prevalence of
6.6 ventilated patients for every 100,000 inhabitants,
shows the current wide use of HMV.5 Although this fact is
positive because the symptoms, arterial blood gases, and
quality of life of the patients improve under HMV,
a commitment to adaptation and follow-up implies the
greater use of medical resources, especially when carried
out in a hospital.
Therefore, it is necessary to find alternatives to the
hospital framework, not only to benefit the patients, but
also to achieve more cost-effective treatments and to
reduce medical expenses.
The global framework of medical assistance changes
over time with scientific progress and limitations on
existing medical resources. The currently available tech-
niques allow different types of medical assistance. Both
telemonitoring and home hospitalization are forms of
medical assistance that have increased dramatically and
can be used when the specialized equipment is available
and patients are chosen appropriately.6 Home hospitali-
zation (HH) has been demonstrated to be as efficient or
more efficient than conventional hospitalization, and
there is evidence that it is more cost effective.7,8 Several
groups have used HH resources in patients with COPD and
asthma, with good results and improved patient
comfort.9,10
Most groups committed to HMV conduct the
traditional adaptation and follow-up of their patients in
hospital.
Our objective was to examine whether home adaptation
and follow-up of patients receiving HMV for chronic respi-
ratory failure, secondary to restrictive ventilatory disor-
ders, is as efficacious as traditional procedures in achieving
the improvements in arterial blood gases, lung function,
and quality of life seen previously. For this purpose, we
used the existing resources at our hospital, which has an
effective HH unit (HHU).Patients and methods
We performed an observational prospective study in which
patients with restrictive ventilatory disorders (neuromus-
cular or thoracic cage disorders, obesityehypoventilation
syndrome [OHS],or diaphragmatic relaxation)were included.
They were referred to the Hospital la Fe Pneumology Service
to be evaluated and included in the HMV program between
June 2003 andJune 2006. Twogroupswere established: group
1, in which patients underwent hospital adaptation, and
group 2, in which ambulatory adaptation was undertaken in
the patient’s home. Patients were allocated to the groups
based onwhether they lived in the geographical area covered
by the HHU of our hospital. No socioeconomic differences
were observed between the groups because all the patients
came from the same medical area.
Initially, at the 3- and 6-month follow-ups, spirometry
(Collins GS and GSIIPLUS, Warren E. MA, EEUU), lung
volume (Collins BO-XII plethysmograph), and maximum
static pressure (Collins Static Pressure System) were per-
formed according to the Spanish Society of Pneumology and
Thoracic Surgery Lung Function Guide; arterial blood gas
analysis (ABL520 and ABL700, Radiometer, Copenhagen,
Denmark), nocturnal pulse oximetry (Ohmeda Oximeter
3000, CO, USA), a generic (SF-36) quality of life ques-
tionnaire, and the Borg scale for dyspnea were applied.11,12
We also initially used the Barthel index as a measure of
patients’ activities of daily living.13
Adaptation to ventilation and follow-up were conducted
by two assistant pneumologists with broad experience in
ventilation: one from the Department of Pneumology and
the other from the HHU at our hospital. The nursing teams,
in both groups, were familiarized with and had experience
in ventilation. In both groups, adaptation and follow-up
were performed in accordance with the protocol estab-
lished in 1997, which was subsequently revised in 2003
(Appendices A and B). Once the ventilator interphase and
adequate parameters were chosen for each patient, we
initiated noninvasive ventilation: 2 h of ventilation in the
morning and 2 h in the afternoon for the first 2e3 days, with
subsequent night ventilation. In all cases, control pulse
oximetry and blood gas analysis were performed at the
patient’s home. The health survey questionnaire SF-36 was
completed by the patient and was always assessed by the
same researcher.
Statistical study
Data obtained were analyzed using the statistical software
package SPSS 11.0. First, we performed a Kolmogorove
Smirnov normality test and a descriptive study of the vari-
ables to be analyzed.
With Student’s t-test for paired samples, we analyzed
the variations observed in each group, comparing initial
Home versus hospital mechanical ventilation 1523baseline data with those obtained at the 3- and 6-month
follow-ups to ascertain whether the parameters were
maintained, increased, or decreased during the follow-up.
The same analysis was performed for independent data, to
compare the two groups at the beginning of the follow-up,
and at the 3- and 6-month follow-ups, to ascertain whether
there were any differences between them. The results are
presented as means and standard deviations, and a P value
of <0.05 is considered significant.Results
Forty-two patients were included in the study, 21 (nine men
and12women) adapted in a conventional hospitalward (group
1) and 21 (seven men and 14 women) adapted at home (group
2). The distributions of the diagnoses are shown in Fig. 1.
All of the study variables fulfilled the normality criterion.
The mean age of the hospital adaptation patients was 59
(17.3) years, and the mean Barthel index was 52.62
(23.4). In the ambulatory group, the mean age was 58.6
(14.88) years, and the Barthel index was 64.29 (26.05).
No significant differences between the two groups were
observed for any of the variables.
No significant differences were observed in the Borg
scale when both groups were compared at the beginning of
the follow-up period, or at the 3- or 6-month follow-ups.
When the hospital adaptation group was compared with
Student’s t-test for paired samples at the beginning of thethoracic cage disorders
neuromuscular disorders
O.H.S
diaphragmatic relaxation
DiagnosisHospital adaptation
thoracic cage disorders
neuromuscular disorders
O.H.S
diaphragmatic relaxation
DiagnosisHome adaptation
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Figure 1 Diagnosis distributions.follow-up period and after 3 months, the difference was
significant (PZ 0.001) and the difference was also signifi-
cant after 6 months (PZ 0.000). Identical results were
found in the home adaptation group.
No statistically significant improvement was observed on
the pulmonary function tests between the initial measure-
ments and those made at 3 and 6 months for both groups, on
both intergroup and individual comparisons.
Significant improvements in arterial blood gases (PaO2,
PaCO2, SaO2, and HCO3) and nocturnal pulse oximetry were
observed in both groups when baseline measurements were
compared with those at 3 months (PZ 0.000) and 6 months
(PZ 0.000). We observed significant differences between
the initial SaO2 of both groups (PZ 0.023) and HCO3
(PZ 0.018), and obtained higher figures for the ambulatory
group. These differences disappeared after 3 months.
PaO2, PaCO2, and SaO2 were significantly different between
the groups after 6 months, and the ambulatory group had
better results (PZ 0.000, PZ 0.020, and PZ 0.033,
respectively). No differences were observed for nocturnal
pulse oximetry (see Table 1).
The results of the SF-36 analysis were analyzed sepa-
rately for each group, using Student’s t-test for paired
data: relative to the start of the follow-up period, a signif-
icant improvement was observed in the hospital group in all
the domains at 3 months, except for physical functioning
and general health. After 6 months of follow-up, these
differences relative to the baseline values were maintained
in the hospital group, and the improvement in the general
health domain became significant. Similar results were
obtained for the home group, except for the general health
domain, which was significantly improved at 3 months and
maintained this improvement until the end of the follow-up
period. The relevant clinical changes in SF36 in both groups
of patients are exposed in Table 2A and B,14 the ambulatory
group had higher score in general health domain.
When the groups were compared with Student’s t-test
for independent samples: the vitality and social functioning
domains differed significantly between the groups at the
beginning of the follow-up period, but this difference in the
vitality domain disappeared after 3 months. At 6 months,
differences that benefited the hospital group were noted in
the social functioning and emotional role domains. A
significant difference was apparent in the general health
domain (PZ 0.02) after 6 months, with a higher score for
the ambulatory group (Table 3).Discussion
To the best of our knowledge, this is the first work to
examine both the adaptation to HMV and the follow-up at
the patient’s home under strict HH control.
Having a good infrastructure and adequate equipment,
staff has allowed HH to be as efficient as conventional
hospitalization.15 Conversely, and like Diaz-Lobato, we
believe that the motivation, experience, and dedication of
the staff in charge are more important than the site at
which adaptation takes place in achieving the correct
management and development of an HMV program.16
This study was a prospective observational study in
which the patients were allocated to treatments according
Table 1 Comparison of blood gases between both groups with time: mean (standard deviation), level of significance
t-Test for independent samples
Baseline 3 months 6 months
Hospital Home P Hospital Home P Hospital Home P
PaO2 62 (14.3) 69 (12.7) 0.07 73(8.2) 77 (8.7) 0.09 74 (6.4) 79 (7.6) 0.02*
PaCO2 53 (10.4) 49 (6.7) 0.12 45(4.7) 42 (3.3) 0.06 43 (3.4) 41 (2.9) 0.03*
pH 7.4(0.03) 7.39(0.03) 0.19 7.4(0.02) 7.4(0.01) 0.75 7.39(0.04) 7.4(0.03) 0.09
SaO2 88 (7.6) 93(4.2) 0.02* 95(1.9) 96(1.5) 0.14 95 (1.4) 96 (0.9) 0.00*
HCO3 32 (3.4) 29 (2.3) 0.02* 29(2.4) 28(2.1) 0.08 28 (1.7) 28 (2.0) 0.31
CT 90 21(12.6) 24 (24.9) 0.62 4(5.6) 3 (3.8) 0.57 0.7 (1.2) 0.5(1.2) 0.62
PaO2, arterial O2 pressure measured in mmHg; PaCO2, arterial CO2 pressure measured in mmHg; SaO2, % arterial O2 saturation; HCO3,
bicarbonate measured in mEq/L; CT 90, Total time, in minutes, spent by the patient under 90% SaO2 in nocturnal pulse oximetry.
*Statistical significance <0.05.
1524 R. Dome´nech-Clar et al.to their home locations, but within the same medical area
and with patients of the same race (a Mediterranean
Spanish population). No differences were observed in the
initial characteristics of the patients on the Borg scale,
respiratory function test, age, or diagnosis. Therefore, we
consider the comparison of the two groups to be valid.
Very few works have examined the results of adaptation
to HMV in alternative places to conventional hospitals. In
a recent project with 16 patients and a 3-month follow-up,
Lujan et al. compared the results obtained with an adap-
tation protocol involving outpatient visits compared with
the usual adaptation in hospital wards, and the same
results were obtained at lower financial cost.17 Our results
for the improvements in arterial blood gases and nocturnal
pulse oximetry are similar to those obtained by those
authors, and we observed a satisfactory result regarding
quality of life over a 6-month follow-up period.
No relation exists between family doctors and pneu-
mologists in our country and it’s necessary to ameliorateTable 2 Changes for each domain in SF-36 pre HMV to 6 mon
significant change14
Domain
A. Hospital adaptation
Hospital patients, nZ 21 Physical functioning
Role physical
Bodily pain
General health
Vitality
Social functioning
Role emotion
Mental health
B. Home adaptation
Outpatients, nZ 21 Physical functioning
Role physical
Bodily pain
General health
Vitality
Social functioning
Role emotion
Mental healththis fact. Collaboration between pneumology services and
HHUs is necessary to establish bonds with family doctors
and therefore to improve the quality of assistance available
to ventilated patients.18e20
In our study, no changes were noted in the maximum
static pressure, spirometry, or lung pressure in either of the
two groups during the 6-month follow-up, consistent with
other series.21e23
Studies published by Barbe´ et al. and Annane et al. of
patients receiving HMV for restrictive ventilatory disorders
showed an improvement in daily arterial blood gases at
follow-up for 18 months and 3 years, respectively.24,25 The
patients in the present series showed a significant
improvement in arterial blood gases in both groups during
follow-up, as did those with dyspnea, which was measured
on the Borg scale. However, those patients adapted in their
homes showed greater improvement in arterial blood gases
than that of patients adapted in hospital. This is attribut-
able to both the training of the patients and technicallyths post HMV in Hospital and home adaptation: Clinically
Baseline Six months Clinically significant
change
40 (19.7) 39 (21.4) No change
13 (22.8) 93 (14.0) Large
64 (23.9) 75 (24.4) Small
45 (17.1) 57 (17.1) Small
48 (15.9) 67 (10.7) Small
76 (25.7) 99 (13.6) Small
40 (31.5) 99 (16.4) Large
56 (12.8) 70 (12.2) Small
39 (20.5) 37 (24.1) No change
20 (25.7) 92 (16.5) Large
57 (23.7) 81 (21.8) Moderate
31 (11.5) 68 (11.5) Large
39 (21.5) 61 (18.3) Small
53 (28.7) 88 (16.4) Moderate
43 (28.9) 86 (19.5) Large
49 (18,0) 68 (15,6) Small
Table 3 Changes for each domain in SF-36 pre HMV to 6 months post HMV: Comparison between the two groups over time:
mean (standard deviation), level of significance
SF-36 Baseline Six months
Hospital Home P Hospital Home P
Physical function 40 (19.6) 39 (20.5) 0.77 39 (21.3) 37 (24.1) 0.81
Role physical 13 (22.8) 20 (25.7) 0.91 93 (14.0) 92 (16.4) 0.80
Bodily pain 64 (23.8) 57 (23.7) 0.39 75 (24.4) 81 (21.8) 0.36
General health 45 (17.1) 31 (11.4) 0.35 57 (17.1) 68 (11.5) 0.02*
Vitality 48 (15.9) 39 (21.4) 0.00* 67 (10.6) 61 (18.3) 0.18
Social functioning 76 (25.7) 53 (28.7) 0.01* 99 (5.4) 88 (16.4) 0.00*
Emotional role 40 (32.5) 43 (28.9) 0.72 98 (7.2) 86 (19.5) 0.01*
Mental health 56 (12.8) 49 (17.9) 0.13 70 (12.2) 68 (15.6) 0.53
*Statistical significance <0.05.
Home versus hospital mechanical ventilation 1525skilled personnel in handling the respirator, and other
elements, such as the quality control of the equipment
used. This is considered an important pillar of the long-
term application of such treatments. Indeed, these results
can be attributed to the fact that this training is performed
in the patient’s home, with adaptation to the different
characteristics of the home, while any possible lack of such
characteristics is noted.26,27
The improvement in quality of life has been described by
several groups.28 In our patients, initial differences were
found in the vitality and social functioning domains with the
SF-36 health survey, and the hospital-adapted patients scored
higher. However, these differences persisted only in the social
functioning domain during the follow-up. The same occurred
with the mental role domain, and as in the previous case, no
evidence was found of differences, because socioeconomic
disparity was unlikely to be a factor within the same medical
area. However, no detailed analysis of families has beenmade
in this regard. The changes in the emotional role domain are
noteworthy in that this scorewas initially lower in the hospital
group than in the ambulatory group, but increased until it was
significantly higher in the hospital-adaptedgroupat the3- and
6-month follow-ups. A possible explanation for this is that
hospital adaptation provided patients with a stronger feeling
of ‘‘protection’’ or with a stronger perception of ‘‘company’’
based on their contact with other patients in a similar situa-
tion. However, the score for the general health domain was
significantly higher in the ambulatory group, which was
perhaps influenced by the fact that they considered them-
selves less ‘‘ill’’ when not hospitalized.
Our results allow us to propose that adaptation and
follow-up in the patient’s home through HH is as efficient as
that conducted within the hospital framework, but with the
added benefit of utilizing the patient’s family environment.
The aim of this study was to identify alternatives to the
characteristic treatment of these patients in our hospitals,
and not to establish the best place to adapt patients to
HMV. Before any innovative strategy is designed, all the
elements facilitating or hindering the introduction of this
strategy must be considered.
Conclusions
 Noninvasive ventilation improved arterial blood gases
and quality of life in patients with restrictive ventila-
tory disorders. Postventilation arterial blood gases were better in
patients adapted at home, whereas quality of life was
similar in both groups.
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Adaptation and follow-up protocol (until 6th
month). Hospital La Fe, 2003
ADAPTATION TO HMV: Hospital and home
e Day 1:
Quality of life questionnaire (SF-36) Borg dyspnea score
and degree of dependency (Barthel index) are
measured.
We decide the type of mask the patient will use and we
adapt it.
We initiate ventilation, 2 h/morning and 2 h/afternoon,
with no nocturnal ventilation.
e Day 2*: Continue with daily ventilation, 2 h/morning
and 2 h/afternoon.
e Days 3 and 4*: We initiate nocturnal ventilation (for at
least 6 h).
e Days 4 and 5: Only nocturnal ventilation. We assess
ventilation efficacy with:
Arterial blood gases at baseline (3 h after ending
nocturnal ventilation);
Nocturnal pulse oximetry with ventilation.
If hypoxemia is not corrected, oxygen can be
added.
e Days 5 and 6: If the results are acceptable (disap-
pearance or decrease of hypercapnia to at
least 10 mmHg, with normal pH), the patient is
discharged.
*Days 2e3 or 4: Visit to a physiotherapist to start respi-
ratory rehabilitation (coughing techniques, etc.).
1526 R. Dome´nech-Clar et al.FOLLOW-UP OF PATIENT RECEIVING HMV until the 6th
month: Hospital and home
e 1st MONTH:
Arterial blood gases: at the hospital or by HH
Standard clinical visit: Pneumology Outpatients
consultation or HH pneumologist
e 3rd MONTH:
Standard clinical visit and SF-36 questionnaire, Borg
and Barthel indices in a Pneumology Outpatients
consultations or patient’s homeAdaptation to HMV
Day 1 Day 2 Days
Pneumologist Initial visit Clinical visit Clinic
Adaptation Tolerance Tolera
Parameters Synchrony Synch
Modifi
Nurse Clinical visit Clinical visit Clinic
Tolerance Tolerance Tolera
Training Problems Proble
Training Traini
Physiotherapist Visit Visit
Respiratory
exercises
Respi
HMV follow-up: Home or pneumology outpatients
consultation
Pneumologist Nurse Physiotherapist
1st month Clinical
visit
Arterial gases
3rd month Clinical
visit RFT
SF-36
questionnaire
and Borg scale
Clinical
visit
Arterial gases
Nocturnal pulse
oximetry
6th month Clinical
visit RFT
SF-36
questionnaire
and Borg scale
Clinical
visit
Arterial gases
Nocturnal pulse
oximetryRespiratory function test (RFT): spirometry, volumes,
maximum static pressure
Physiotherapist visit (hospital/home)
Arterial blood gases
Nocturnal pulse oximetry
e 6th MONTH:
Clinical visit, questionnaire, and Pneumology Outpa-
tients consultations or patient’s home
RFT: spirometry, volumes, maximum static pressure
Home: Spirometry and pressures
Arterial blood gases/nocturnal pulse oximetry
Physiotherapist visit3/4 Days 4/5 Days 5/6
al visit Clinical visit Discharge visit
nce Tolerance
rony Synchrony
cation parameters
al visit Clinical visit Clinical visit
nce Arterial gases
ms Pulse oximetry
ng
ratory exercisesAppendix B
Data sheet for each clinical visitSymptoms and
complications*
HMV
start
Follow-up
dates
Dyspnea
Somnolence
Cephalea
Inefficient cough
Voice changes
Deglution disorders
Aerophagia
Mouth dryness
Rhinitis
Conjunctivitis
Pressure ulcers
Ventilator HMV
start
Follow-up
dates
Hours/day of use
Nocturnal/daily use
Tolerance**
*Symptoms 0e5 (0Z none; 1Z few; 2Z moderate;
3Z several; 4Zmany; 5Zmost).
**Tolerance: 0Z none; 1Z little; 2Zmoderate; 3Z good;
4Z very good; 5Z excellent.
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